Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Lancet (London, England)
|
November 7, 1987
Treatment for myelodysplastic syndromes
A Pagliuca, D M Layton, G J Mufti
Blood Reviews
|
September 1, 1995
Hereditary red cell enzymopathies
R Arya, D M Layton, A J Bellingham
Blood Cells, Molecules & Diseases
|
November 27, 1999
The consequence of nucleotide substitutions in the triosephosphate isomerase (TPI) gene promoter
A Humphries, A Ationu, B Wild, et al.
Blood Cells, Molecules & Diseases
|
November 27, 1999
Unique and recurrent WAS gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
L J Thompson, M R Lalloz, D M Layton
BMJ (Clinical Research Ed.)
|
December 3, 1988
Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant
A Pagliuca, D M Layton, S Allen, et al.
Human Genetics
|
August 24, 1999
Ancestral origin of variation in the triosephosphate isomerase gene promoter
A Humphries, A Ationu, M R Lalloz, et al.
Blood Cells, Molecules & Diseases
|
January 11, 2002
Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region
S F Ofori-Acquah, M R Lalloz, D M Layton
Biochemical and Biophysical Research Communications
|
January 28, 1999
Localisation of cis regulatory elements at the beta-globin locus: analysis of hybrid haplotype chromosomes
S F Ofori-Acquah, M R Lalloz, D M Layton
Human Mutation
|
January 1, 1997
Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency
R Arya, M R Lalloz, A J Bellingham, et al.
Leukemia
|
March 1, 1991
Cross-lineage rearrangement of antigen receptor genes in atypical chronic myeloid leukemia
M H Mangi, D M Layton, K Tobal, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Lancet (London, England)
|
November 7, 1987
Treatment for myelodysplastic syndromes
A Pagliuca, D M Layton, G J Mufti
Blood Reviews
|
September 1, 1995
Hereditary red cell enzymopathies
R Arya, D M Layton, A J Bellingham
Blood Cells, Molecules & Diseases
|
November 27, 1999
The consequence of nucleotide substitutions in the triosephosphate isomerase (TPI) gene promoter
A Humphries, A Ationu, B Wild, et al.
Blood Cells, Molecules & Diseases
|
November 27, 1999
Unique and recurrent WAS gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
L J Thompson, M R Lalloz, D M Layton
BMJ (Clinical Research Ed.)
|
December 3, 1988
Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant
A Pagliuca, D M Layton, S Allen, et al.
Human Genetics
|
August 24, 1999
Ancestral origin of variation in the triosephosphate isomerase gene promoter
A Humphries, A Ationu, M R Lalloz, et al.
Blood Cells, Molecules & Diseases
|
January 11, 2002
Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region
S F Ofori-Acquah, M R Lalloz, D M Layton
Biochemical and Biophysical Research Communications
|
January 28, 1999
Localisation of cis regulatory elements at the beta-globin locus: analysis of hybrid haplotype chromosomes
S F Ofori-Acquah, M R Lalloz, D M Layton
Human Mutation
|
January 1, 1997
Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency
R Arya, M R Lalloz, A J Bellingham, et al.
Leukemia
|
March 1, 1991
Cross-lineage rearrangement of antigen receptor genes in atypical chronic myeloid leukemia
M H Mangi, D M Layton, K Tobal, et al.
Page
of 6